Skip to main content

Featured

Ontario's 2027 Rent Increase Guideline Is 1.9% — What Landlords and Tenants Need to Know Before October

  August 16, 2026 If you own a rental property in Ontario — or rent one — mark October 3 on your calendar. That's the earliest a landlord can legally serve notice for a rent increase that takes effect January 1, 2027, and it's the practical starting gun for a guideline that's quietly gotten tighter for the third year in a row. The province has set the 2027 rent increase guideline at 1.9% , down from 2.1% in 2026 and well off the 2.5% legal ceiling that held for three straight years before that. It's the lowest guideline Ontario has published in years — and while that sounds like a straightforward win for tenants, the real story for both sides is in the timing, the exemptions, and what a below-inflation-feeling number actually does to a landlord's math. What It Means for You Landlords: the earliest you can serve a valid N1 notice for a January 1, 2027 increase is October 3, 2026 — 90 days' notice is mandatory. Tenants: a 1.9% cap only applies if your unit is rent...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments